alexa Extracts From Graviola Transcriptionally Inhibits The Expression Of Receptors In Breast Cancer Cells | 66720
ISSN: 2329-6836

Natural Products Chemistry & Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Marine Drugs and Natural Products

Terry Roberts and Evgeny Makarov
Kings College London, UK
Posters & Accepted Abstracts: Nat Prod Chem Res
DOI: 10.4172/2329-6836-C1-014
Abstract
Statement of the Problem: Annonaceous acetogenins extracted from plants of the genera Annona, which includes the species Annona muricata (also known as Soursop, Graviola and Guanabana) are known to have anti-cancer properties. Several published articles, dating back as far as the 1990’s, have shown that acetogenins extracted from the leaves, fruit and seeds can kill breast, prostate, pancreas, skin and liver cancer cells in vitro and in vivo. Cancer Research UK has mentioned that there have not been any large scale studies in humans on the use of Graviola for cancer therapy and no substantial evidence of its anti-cancer activity exists. Therefore our aim is to identify and purify the most active anti-cancer product in crude soursop extracts. We will then test these products on normal and cancer cell lines. Methodology & Theoretical Orientation: An extract was prepared from crushed soursop seeds; it was then subjected to flash chromatography. Six separate extract fractions were identified. These fractions were tested for bioactivity against the breast cancer cell line 21NT and a normal cell line, HMEC. Findings: We found that fractions II and III were approximately 106x more active against cancer cells. HPLC was then used to purify the active compound from fraction II. The HPLC purified compound was then used to treat breast cancer cells for 48 hours, RNA and protein was extracted and used to identify targets that were modulated by the compound. Conclusion & Significance: This compound was shown to be a transcriptional inhibitor of EGFR and LDH, both of which are important for the rapid growth of cancer cells.
Biography

Terry Roberts obtained his PhD in Biotechnology from Kings College London. Currently, he is working within the field of Human Molecular Genetics and Cancer for over 20 years. He made significant contributions towards research into several cancer types including neuroblastoma, melanoma, leukemia, prostate and breast cancer. He was involved in the cloning and analysis of the novel genes GFI-1, NB4S, TRNG10, PCTA-1 HGRG8, and TTC4. He had an extensive knowledge of cancer genetics in the field of natural medicine and translational biology to help elucidate pathways through which natural products work.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version